- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: NDI-034858 study drug
Total 4226 results
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
TakedaNimbus Lakshmi, Inc.CompletedPsoriatic ArthritisUnited States, Czechia, Germany, Poland
-
Cocrystal Pharma, Inc.CompletedChronic Hepatitis CUnited States
-
Medical University of LublinCompletedOveractive Bladder | Urinary IncontinencePoland
-
Philogen S.p.A.Boehringer IngelheimCompletedAcute Myeloid Leukemia (AML) RelapseGermany
-
Pearl Therapeutics, Inc.Completed
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; NYU Langone HealthCompletedSkin Cancer | Metastatic Melanoma | NeoplasmUnited States
-
Pearl Therapeutics, Inc.Completed
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnMalignant Neoplasm | Musculoskeletal ComplicationsUnited States
-
SunovionCompleted
-
NexEos Diagnostics, Inc.RecruitingEosinophilic EsophagitisUnited States
-
NovaDigm Therapeutics, Inc.CompletedVulvovaginal CandidiasisUnited States
-
Pearl Therapeutics, Inc.Terminated
-
University of LeedsCompleted
-
Sean LiuActive, not recruitingSARS-CoV-2United States
-
Weill Medical College of Cornell UniversityUniversity of California, Los AngelesTerminatedMetastatic Breast CancerUnited States
-
Carol BernierVirginia Polytechnic Institute and State UniversityRecruitingCardiac Arrest | Pulseless Electrical ActivityUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Germany, Argentina, Bulgaria, Poland, Turkey, Mexico, United Kingdom
-
Ohio State University Comprehensive Cancer CenterRecruitingNicotine | Nicotine Vaping | E-cigarette UseUnited States
-
Bin LiHuazhong University of Science and TechnologyCompletedLeber Hereditary Optic NeuropathyChina
-
Butantan InstituteCompletedCoronavirus Infections | HealthyBrazil
-
Boehringer IngelheimCompleted
-
University Hospital, Basel, SwitzerlandsciCORE University of Basel; Leonhard Med IT ETH Zurich; Swiss Institute of BioinformaticsCompletedSARS Coronavirus (SARS-CoV-2) InfectionSwitzerland
-
Hoffmann-La RocheCompletedHuntington's DiseaseUnited Kingdom, United States, Germany, Canada
-
Valduce HospitalTerminated
-
University of New MexicoAmerican Diabetes AssociationCompleted
-
Nimbus Saturn, Inc.Recruiting
-
GlaxoSmithKlineCompleted
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Pearl Therapeutics, Inc.CompletedCOPDUnited States, Austria, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Peru, Russian Federation, Hungary, China, Taiwan, Australia, Japan, Argentina, South Africa, Belgium, Czechia, Serbia, Poland, Mexico, New... and more
-
Humanity & Health Medical Group LimitedWithdrawnHCV InfectionHong Kong
-
Pearl Therapeutics, Inc.Completed
-
University of AberdeenEuropean UnionCompletedObesityNetherlands, Greece, United Kingdom
-
Grifols Therapeutics LLCCompletedMultiple Sclerosis, Relapsing-RemittingCanada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
-
Pearl Therapeutics, Inc.Completed
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
Grifols Therapeutics LLCCompletedMacular DegenerationGermany
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; National Taiwan University Hospital; Duke... and other collaboratorsTerminatedSmall Cell Lung CancerUnited States, Taiwan, Germany, Belgium, United Kingdom
-
Pearl Therapeutics, Inc.CompletedCOPD, Chronic Obstructive Pulmonary DiseaseBelgium
-
AstraZenecaParexelRecruitingSystemic Lupus ErythematosusItaly, Belgium, Germany, France, Canada, Austria, Sweden, Denmark, Israel, United Arab Emirates
-
Omeros CorporationRecruitingParoxysmal Nocturnal HemoglobinuriaUkraine
-
Bond Avillion 2 Development LPParexelActive, not recruiting
-
AstraZenecaRecruitingChronic Obstructive Pulmonary DiseaseGermany, United Kingdom
-
AstraZenecaParexelRecruitingMajor BleedingUnited States, Japan, Germany, United Kingdom
-
University of ConnecticutUnited States Department of Defense; AMP Human; Park City, UTCompletedCognitive Change | Electrolyte and Fluid Balance Conditions | Fluid Retention | Heat Exposure | Fluid Loss | Hyperhydration | Sodium RetentionUnited States
-
Alexion PharmaceuticalsTerminatedAntiphospholipid (aPL)-PositiveUnited States, Italy, Brazil, France, Japan, United Kingdom
-
Omeros CorporationRecruitingParoxysmal Nocturnal HemoglobinuriaSwitzerland, Germany, Ukraine, United Kingdom
-
Neurocrine BiosciencesTerminatedFocal Onset Seizure | Focal Onset EpilepsySpain, Australia, Belgium, Czechia, France, Hungary, Italy